MILAN — Cellular therapy with adipose-derived mesenchymal stem cells implanted in the corneal stroma may be an alternative to corneal transplantation, according to a study presented here.
“We have performed the first-in-human trial in patients with advanced keratoconus using human autologous adipose-derived adult stem cells (ADASCs), and results at 3 years are encouraging,” Jorge Alió del Barrio, MD, said at the European Society of Cataract and Refractive Surgeons meeting.
Elective liposuction was performed in the abdomen or hips to extract and isolate the cells. A